1. Assessment of Functional Capacity of Immune System in Patients with Multiple Sclerosis using QuantiFERON Monitor. (7th April 2023) Authors: Pavelek, Zbysek; Soucek, Ondrej; Krejsek, Jan; Sejkorova, Ilona; Vysata, Oldrich; Klimová, Blanka; Angelucci, Francesco; Stourac, Pavel; Valis, Martin; Peterka, Marek; Sobisek, Lukáš; Novotny, Michal Other Names: Zhu Lele Academic Editor. Journal: Journal of immunology research Issue: Volume 2023(2023) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Recommendations for the Use of Prolonged‐Release Fampridine in Patients with Multiple Sclerosis (MS). (22nd April 2013) Authors: Preiningerova, Jana Lizrova; Baumhackl, Ulf; Csepany, Tunde; Czaplinski, Adam; Deisenhammer, Florian; Derfuss, Tobias; Fabjan, Tanja H.; Fazekas, Franz; Fuchs, Siegrid; Havrdova, Eva; Ledinek, Alenka Horvath; Illes, Zsolt; Jazbec, Sasa Sega; Klimova, Eleonora; Komoly, Samuel; Kurca, Egon; Linneba... Journal: CNS neuroscience & therapeutics Issue: Volume 19:Number 5(2013) Page Start: 302 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Safety and efficacy of tolebrutinib, an oral brain-penetrant BTK inhibitor, in relapsing multiple sclerosis: a phase 2b, randomised, double-blind, placebo-controlled trial. Issue 9 (September 2021) Authors: Reich, Daniel S; Arnold, Douglas L; Vermersch, Patrick; Bar-Or, Amit; Fox, Robert J; Matta, Andre; Turner, Timothy; Wallström, Erik; Zhang, Xinyan; Mareš, Miroslav; Khabirov, Farit A; Traboulsee, Anthony; Grand'Maison, Francois; Jacques, Francois; Traboulsee, Anthony; Tyblova, Michaela; Meluzinov... Journal: Lancet neurology Issue: Volume 20:Issue 9(2021) Page Start: 729 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗